CTIS2023-504879-24-00RecruitingPhase 1
In vivo bioequivalence study of a new clobetasol propionate 0.05% topical cream compared to DERMOVAL® 0.05% cream using the skin blanching bioassay in healthy subjects.
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Substipharm
- Enrollment
- 102
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 64 (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Not yet recruiting
Phase 1
Bioequivalence of ClopidogrelHealthy volunteersHealthy VolunteersRPCEC00000257Center for Pharmaceutical Research and Development, Havana, Cuba.24
Completed
Not Applicable
Comparison of efficacy of topical clobetasol 0.05% plus 5FU 5% cream vs. topical clobetasol 0.05% alone in the treatment of vitiligo.Vitiligo.vitiligoIRCT201203049198N2Isfahan Univercity of Medical Sciences45
Active, not recruiting
Phase 1
Clinical study to assess the efficacy of Clobetasol mouth rinses in patientswith oral lichen planus.MedDRA version: 20.1Level: PTClassification code 10030983Term: Oral lichen planusSystem Organ Class: 10017947 - Gastrointestinal disordersOral lichen planusEUCTR2018-004222-28-SEMalmö University90
Recruiting
Not Applicable
In-vivo Bioequivalence study of Clopidegrel tablet with brand drugs (PLAVIX SANOFI, USA)IRCT20200105046010N35SanaMed Co.24
Active, not recruiting
Not Applicable
Subject preference comparison between Clobetasol propionate shampoo, 0.05 and three other topical corticosteroids in the treatment of moderate to severe scalp psoriasis - NDScalp PsoriasisMedDRA version: 9.1Level: LLTClassification code 10037153Term: PsoriasisEUCTR2006-003073-27-ITGALDERMA R D SNC240